Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
66.23
+1.87 (2.91%)
At close: Apr 9, 2026, 4:00 PM EDT
65.67
-0.56 (-0.85%)
After-hours: Apr 9, 2026, 6:06 PM EDT
Arrowhead Pharmaceuticals Analyst Ratings
Total Analysts
10
Consensus Rating
Strong Buy
Price Target
$81.50
Upside
+23.06%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +50.99% | Mar 25, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +50.99% | Feb 10, 2026 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $61 → $101 | Strong Buy | Maintains | $61 → $101 | +52.50% | Jan 22, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $85 → $100 | Strong Buy | Maintains | $85 → $100 | +50.99% | Jan 21, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $100 → $110 | Buy | Reiterates | $100 → $110 | +66.09% | Jan 13, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $50 → $85 | Hold | Maintains | $50 → $85 | +28.34% | Jan 7, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $48 → $81 | Hold | Maintains | $48 → $81 | +22.30% | Jan 7, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $60 → $80 | Strong Buy | Maintains | $60 → $80 | +20.79% | Jan 7, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $70 → $100 | Buy | Maintains | $70 → $100 | +50.99% | Dec 17, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $52 → $80 | Buy | Maintains | $52 → $80 | +20.79% | Dec 11, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $62 → $81 | Strong Buy | Maintains | $62 → $81 | +22.30% | Dec 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $80 → $85 | Strong Buy | Maintains | $80 → $85 | +28.34% | Dec 2, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $42 → $62 | Strong Buy | Maintains | $42 → $62 | -6.39% | Dec 1, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $60 | Strong Buy | Maintains | $60 | -9.41% | Dec 1, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $45 → $48 | Hold | Maintains | $45 → $48 | -27.53% | Nov 26, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $27 → $48 | Hold | Maintains | $27 → $48 | -27.53% | Nov 20, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.